Navigation Links
Study Confirms It: Booze Impairs Decision-Making
Date:10/19/2010

TUESDAY, Oct. 19 (HealthDay News) -- A new study confirms what many people may know first- or secondhand: Too much alcohol slows reaction time and increases errors during decision-making.

Specifically, the researchers found that alcohol affects certain brain regions involved in error processing more than others.

The study included 38 volunteers who received no alcohol (control group) or different doses of alcohol in order to make them either moderately or highly intoxicated.

They then took a reaction test, which found no significant difference between the control group and those who were moderately drunk. However, the highly intoxicated volunteers had slower reaction time and more errors than the control group.

The study appears online and in the January print issue of the journal Alcoholism: Clinical & Experimental Research.

"Alcohol is widely consumed in our society today. We know it alters behavior, but surprisingly it is not well studied at the brain level. Once we understand how it is altering the brain, we can better inform the public of the consequences of drinking alcohol," lead author Beth Anderson, a postdoctoral fellow at the Olin Neuropsychiatry Research Center at Hartford Hospital in Connecticut, said in journal news release.

More information

The U.S. National Institute on Alcohol Abuse and Alcoholism has more about alcohol and your health.

-- Robert Preidt

SOURCE: Alcoholism: Clinical & Experimental Research, news release, Oct. 19, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Low Testosterone May Raise Risk of Early Death: Study
2. Binge Drinking, Pot Could Put Teens Intellect at Risk: Study
3. Fish Oil Pills Dont Affect Postpartum Depression: Study
4. Study reveals superior sedation method for children
5. Surgery on Wrong Patients, Surgical Sites Persists, Study Finds
6. Web Site for Hospital Comparisons Is Faulty: Study
7. Penn study gives hope for new class of Alzheimers disease drugs
8. Soy May Reduce Breast Cancer Recurrence: Study
9. Kids Medicaid-Covered Flu Shots Put Docs at a Loss: Study
10. Young Kids Easily Trust What Theyre Told: Study
11. Genomic Systems announces moratorium on studying and treating terminal cancer has ended
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Confirms It: Booze Impairs Decision-Making
(Date:1/19/2017)... Antonio, Texas (PRWEB) , ... January 19, 2017 , ... ... the GenCure Tissue Donation Awareness Scholarship competition., The winner will earn a $1,000 scholarship ... accounts. The competition begins Feb. 1, and the deadline is May 31, with the ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Allegheny Health Network ... patients who seek access to the Network’s programs and services in the greater Pittsburgh ... specialty care appointments will be offered one for that same afternoon. , ...
(Date:1/19/2017)... ... January 19, 2017 , ... For ... serves Lawrenceville, New Jersey and the surrounding area, is inaugurating a charity ... (ALS), more commonly known as Lou Gehrig's disease or motor neurone disease, is ...
(Date:1/19/2017)... ... January 19, 2017 , ... For the second consecutive year, ... Connecticut (RMACT) have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. Spencer Richlin, ... been chosen by their peers for the 2017 list based on their exceptional ...
(Date:1/19/2017)... VA (PRWEB) , ... January 19, 2017 , ... The ... Thrive in 2017, **An FDAnews Webinar**, Jan. 26, 2016 — 1:30 p.m. – 3:00 ... about the 21st Century Cures Act in order to thrive this year? , The ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017  Abaxis, Inc. (NasdaqGS: ABAX ... instruments and consumables for the medical and veterinary markets ... financial results for the third quarter fiscal year 2017, ... 4:15 p.m. ET on Thursday, January 26, 2017.  The ... fiscal year 2017 after the market closes on Thursday, ...
(Date:1/19/2017)... Jan. 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... specializing in the treatment of non-melanoma skin cancers ... superficial radiation therapy, today announced that it will ... financial results on Thursday, February 2, 2017 after the ... a conference call with the investment community on Thursday, ...
(Date:1/19/2017)... , January 19, 2017 Shire ... that the U.S. Food and Drug Administration (FDA) has ... New Drug Application (NDA) for SHP465, a long-acting, triple-bead, ... a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The ... around June 20, 2017, the designated Prescription Drug User ...
Breaking Medicine Technology: